Supernus Pharmaceuticals | SUPN - 贸易债权人

金融业

USD

USD 1.5B

现金及等价物

USD 184.87M

USD 49.04M

USD 731.58M

USD 373.93M

USD 40.98M

USD -35.25M

USD 29.23M

674

EPS每股收益

USD 0.6

股本和储备

USD 1.08B

USD 129.36M

债务利息支出

USD 910K

USD 2.02M

USD 400.38M

USD 2.56B

USD -2.29M

USD 1.08B

USD -35.25M

普通股股本

USD 58.04M

44.21

USD -5.95M

USD 207.71M

销售和管理费用

USD 118.23M

USD 110.77M

贸易债权人

USD 10.17M

应收帐款人

USD 182.18M

	贸易债权人	更改		日
Abbott	USD 4.24B		117M	2025-12
ANI Pharmaceuticals	USD 69.69M		7.11M	2026-03
Aurora Cannabis	CAD 68.03M		18.68M	2025-12
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Canopy Growth	CAD 19.96M		1.83M	2025-12
Cara Therapeutics	USD 3.22M		859K	2025-12
Corcept Therapeutics	USD 33.31M		7.14M	2026-03
Eisai	JPY 75.89B		9.6B	2026-03
Eli Lilly	USD 5.03B		350M	2026-03
Novo Nordisk	DKK 14.8B		4.96B	2026-03
Pacira	USD 14.01M		1.14M	2026-03
Perrigo	USD 434.8M		39.7M	2026-03
Pfizer	USD 4.51B		734M	2026-03
Supernus Pharmaceuticals	USD 10.17M		97.63M	2026-03
United Therapeutics	USD 498.3M		491.2M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03